HONOLULU – The Hawai‘i Department of Health (DOH) is pausing use of the Johnson & Johnson COVID-19 vaccine while the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) review data involving six cases in which individuals who received the Johnson &Johnson vaccine developed blood clots.
“We’re are pausing out of an abundance of caution. Vaccine safety is of the utmost importance,” said Health Director Dr. Elizabeth Char. “The risk of developing a blood clot is very low. About 6.8 million Johnson & Johnson vaccines have been administered in the United States. Six people have developed blood clots.”
The blood clots, called cerebral venous sinus thrombosis, occurred in women ages 18 to 48. Symptoms occurred 6 to 13 days after vaccination.
There are no reports of anyone in Hawai‘i developing blood clots after receiving a Johnson & Johnson vaccine. People who received a Johnson & Johnson vaccine within the past few weeks should monitor themselves for symptoms and contact their healthcare provider if they experience a severe headache, abdominal pain, leg pain, or shortness of breath.
“I still have confidence in the vaccine. These adverse events appear to be extremely rare, but this transparent and deliberate pause ensures the medical community is aware of the potential adverse events.” Char said.
Some vaccination providers scheduled to administer Johnson & Johnson vaccine in the coming days may offer Pfizer or Moderna vaccine instead.
The Pfizer and Moderna vaccines, which use different delivery technology than the Johnson & Johnson vaccine, continue to be used in Hawai‘i and around the country. Scheduling opportunities can be found on the registration page at hawaiicovid19.com.
For more information, see the official CDC-FDA release: https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine
# # #
Denby Fawcett: Why So Few People Are Getting The New Covid Shot
Experts are worried about the lack of interest as people are still suffering from the virus and long Covid. By Denby Fawcett Original article on Civil Beat, November 7, 2023 I keep a card in my [...]
Federal Public Health Emergency (PHE) for COVID-19 ends on May 11, 2023
HONOLULU, HI –The federal Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public Health Service Act, will expire at the end of the day on May 11, 2023. As the PHE [...]
Seniors now eligible for additional COVID-19 bivalent booster dose, COVID vaccine recommendations simplified
HONOLULU, HI – The Hawai‘i Department of Health (DOH) supports the latest recommendations announced yesterday by the Centers for Disease Control and Prevention (CDC), allowing an additional dose of the bivalent booster against the virus [...]
Hawai‘i COVID-19 hospitalizations on the rise
HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]
Wastewater Samples Show Higher COVID Concentrations & New Subvariant
The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]
Bivalent boosters for keiki as young as 6 months
Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]